| Parkinson’s disease (PD) is considered as a high
prevalence neurodegenerative disorders worldwide.
Pathologically, the demise of dopamine-producing cells, in
large part due to an abnormal accumulation of the asynuclein
in the substantia nigra, is one of the main causes
of the disease. Up until now, many de novo investigations
have been conducted to disclose the mechanisms underlying
in PD. Among them, impacts of non-coding RNAs
(ncRNAs) on the pathogenesis and/or progression of PD
need to be highlighted. microRNAs (miRNAs) and long
ncRNAs (lncRNAs) are more noteworthy in this context.
miRNAs are small ncRNAs (with 18–25 nucleotide in
length) that control the expression of multiple genes at
post-transcriptional level, while lncRNAs have longer size
(over 200 nucleotides) and are involved in some key biological
processes through various mechanisms. Involvement
of miRNAs has been well documented in the
development of PD, particularly gene expression. Hence, in
this current review, we will discuss the impacts of miRNAs
in regulation of the expression of PD-related genes and the
role of lncRNAs in the pathogenesis of PD. |